If you are:
FDB Contraindicated or Not Recommended: FDA C BEFORE 30WKS;PREMATURE CLOSURE OF DUCTUS ARTERIOSUS;EARLY MISCARRIAGE RISK
Precaution: LIMITED DATA;MINIMAL MILK AND INFANT BLOOD LEVELS;NO ADV EVENTS YET REPORTED.
An adult over 60:
management or monitoring precaution: Gastrointestinal-Risk for ulceration or serious GI bleed; highest with history of PUD or GI bleed. Renal-Risk for exacerbation of CKD. Cardiovascular-May exacerbate pre-existing hypertension or CHF. Risk of cardiovascular thrombotic events, including MI and stroke. This risk may occur early in treatment and increases with duration of use. Risk for reinfarction with minimal NSAID use post-MI. Contraindicated with CABG. Hepatic-Elevated hepatic transaminases may occur with chronic use.
Giving Celebrex to a child under 12:
management or monitoring precaution: Risk of disseminated intravascular coagulation with systemic onset juvenile rheumatoid arthritis.
management or monitoring precaution: Safety and efficacy not established in children age under 2 years.